Future perspectives on the treatment issues associated with cancer and aging

Cancer

Volumn 113, Issue 12 SUPPL., 2008, Pages 3512-3518

  Trask, Peter C ^a,b   Blank, Thomas O ^c   Jacobsen, Paul B ^d  

^a PFIZER INC   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Aging; Cancer; Perspectives; Treatment

Indexed keywords

AGING; CANCER CHEMOTHERAPY; CANCER RESEARCH; CANCER SURGERY; CANCER THERAPY; COMORBIDITY; CONFERENCE PAPER; DECISION MAKING; GERIATRIC ASSESSMENT; GERONTOLOGY; HEALTH CARE PERSONNEL; LUNG NON SMALL CELL CANCER; NEOPLASM; ONCOLOGY; PERFORMANCE; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE;

AGED; AGING; COMORBIDITY; HUMANS; NEOPLASMS; PALLIATIVE CARE; RESEARCH DESIGN;

EID: 59449089249     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23940     Document Type: Conference Paper

References (41)

1. Balducci L. Epidemiology of cancer and aging. J Oncol Manag. 2005;14:47-50.
2. Balducci L. Cancer in the older person. Generations. 2007;30:45-50.
3. Yancik R, Ries LAG. Cancer in older persons: an international issue in an ageing world. Semin Oncol. 2004;31:128- 136.
4. Given B, Given CW. Older adults and cancer treatment. Cancer. 2008;113(12 suppl):000-000.
5. Baider L, Cooper CL, Kaplan De-Nour A. Cancer and the Family. 2nd ed. New York, NY: John Wiley & Sons, Inc.; 2000.
6. Kitrungroter L, Cohen MZ. Quality of life of family caregivers of patients with cancer: a literature review. Oncol Nurs Forum. 2006;33:625-632.
7. Servaes P, Verhagen C, Bleijenberg G. Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. Eur JCancer. 2002;38:27-43.
8. Sanoff HK, Goldberg RM, Pignone MP. A systematic review of the use of quality of life measures in colorectal cancer research with attention to outcomes in elderly patients. Clin Colorectal Cancer. 2007;4:700-709.
9. Blank T, Bellizzi K, Murphy K, Ryan K. How do men ''make sense'' of their prostate cancer? Age and treatment factors [abstract]. Gerontologist. 2003;43(special issue 1):342-343.
10. Bellizzi KM, Blank TO, Oakes CE. Social comparison processes in autobiographies of adult cancer survivors. J Health Psychol. 2006;11:777-786.
11. VanderZee K, Buunk B, Sanderman R, Botke G, van den Bergh F. Social comparison and coping with cancer treatment. Pers Individ Diff. 2000;28:17-34.
12. Bennahum DA, Fornam WB, Vellas B, Albarede JL. Life expectancy, co-morbidity and quality of life. Clin Geriatr Med. 1997;13:33-53.
13. Harlacher R, Fusgen I. Geriatric assessment in the elderly cancer patient. J Cancer Res Clin Oncol. 2000;126:369-374.
14. Repetto L, Comandini D, Mammoliti S. Life expectancy, co-morbidity and quality of life: the treatment equation in the older cancer patients. Crit Rev Oncol Hematol. 2001; 37:147-152.
15. Monfardini S, Aapro MS, Bennett JM, et al. Organization of the clinical activity of geriatric oncology: report of an SIOG (International Society of Geriatric Oncology) task force. Crit Rev Oncol Hematol. 2007;62:62-73.
16. Steyerberg EW, Neville B, Weeks JC, Earle CC. Referral patterns, treatment choices, and outcomes in locoregional esophageal cancer: a population-based analysis of elderly patients. J Clin Oncol. 2007;25:2389-2396.
17. Lichtman SM, Balducci L, Aapro M. Geriatric oncology: a field coming of age. J Clin Oncol. 2007;25:1821-1823.
18. Schaie KW. A general model for the study of developmental problems. Psychol Bull. 1965;64:92-107.
19. Baltes MM. The Many Faces of Dependency in Old Age. New York, NY: Oxford University Press; 1996.
20. August DA, Rea T, Sondak VK. Age-related differences in breast cancer treatment. Ann Surg Oncol. 1994;1:45-52.
21. Merchant TE, McCormick B, Yahalom J, Borgen P. The influence of older age on breast cancer treatment decisions and outcome. Int J Radiat Oncol Biol Phys. 1996;34:753-755.
22. Townsley CA, Selby R, Siu LL. Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials. J Clin Oncol. 2005;23:3112-3124.
23. Jackman DM, Yeap BY, Lindeman NI, et al. Phase II clinical trial of chemotherapy-naive patients ≥70 years of age treated with erlotinib for advanced non-small-cell lung cancer. J Clin Oncol. 2007;25:760-766.
24. Aldwin CM, Spiro A, Park CL. Health, behavior, and optimal aging. In: Birren JE, Schaie KW, eds. Handbook of the Psychology of Aging. 6th ed. San Diego, Calif: Academic Press; 2006:85-104.
25. Brandtstaedter J, Renner G. Tenacious goal pursuit and flexible goal adjustment: explication of age-related analysis of assimilative and accommodative strategies of coping. J Pers Soc Psychol. 1990;65:58-67.
26. Carstensen LL, Isaacowitz DM, Charles ST. Taking time seriously: a theory of socioemotional selectivity. Am Psychol. 1999;54:165-181.
27. Carstensen LL, Mikels JA, Mather M. Aging and the intersection of cognition, motivation, and emotion. In: Birren JE, Schaie KW, eds. Handbook of the Psychology of Aging. 6th ed. San Diego, Calif: Academic Press; 2006:343-362.
28. Altman SH, Schactman DI. Policies for an Aging Society. Baltimore, Md: Johns Hopkins Press; 2002.
29. Moon M. Organization and financing of health care. In: Binstock RH, George LK, eds. Handbook of Aging and the Social Sciences. 6th ed. San Diego, Calif: Academic Press; 2006:380-396.
30. Baltes PB, Reese HW, Nesselroade JR. Lifespan Developmental Psychology: Introduction to Research Methods. Pacific Grove, Calif: Brooks/Cole; 1977.
31. Heckhausen J. Developmental Regulation in Adulthood. New York, NY: Cambridge University Press; 2006.
32. Craik FIM, Salthouse TA. Handbook of Aging and Cognition. 2nd ed. Mahwah, NJ: Lawrence Erlbaum; 2000.
33. Marsiske M, Margrett JA. Everyday problem solving and decision making. In: Birren JE, Schaie KW, eds. Handbook of the Psychology of Aging. 6th ed. San Diego, Calif: Academic Press; 2006:315-342.
34. Park DC, Schwarz N. Cognitive Aging: A Primer. Philadelphia, Pa: Taylor & Francis; 2000.
35. Firat S, Bousamra M, Gore E, et al. Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2002;52: 1047-1057.
36. Piccirillo JF, Tierney RM, Costas I, et al. Prognostic importance of comorbidity in hospital-based cancer registry. JAMA. 2004;291:2441-2447.
37. Frasci G, Lorusso V, Panza N, et al. Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with non-small-cell lung cancer. J Clin Oncol. 2000;18: 2529-2536.
38. Steyerberg EW, Neville BA, Koppert LB, et al. Surgical mortality in patients with esophageal cancer: development and validation of a simple risk score. J Clin Oncol. 2006;24: 4277-4284.
39. Meyerhardt HA, Catalano PJ, Haller DG. Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol. 2003;21:433-440.
40. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM, ed. Evaluation of Chemotherapeutic Agents. New York, NY: Columbia University Press; 1949:199-205.
41. Zubrod CG, Schneiderman M, Frei E, et al. Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chronic Dis. 1960;11:7-33.